US EditionAll states, territories agree to $7.4B Purdue Pharma opioid settlement
- On June 17, 2025, Purdue Pharma and members of the Sackler family agreed to pay $7.4 billion to resolve opioid-related lawsuits with 55 U.S. states and territories.
- The settlement follows a 2019 deal Oklahoma made separately and the Supreme Court's rejection last June of a prior settlement granting Sacklers broad immunity from lawsuits.
- The agreement requires the Sacklers to pay about $6.5 billion, Purdue Pharma $900 million, and for the Sacklers to cede control of Purdue Pharma as payouts begin after creditor approval of Chapter 11.
- Indiana Attorney General Rokita called the settlement a “monumental victory” and said “this is about accountability and justice,” while the funds will go to individuals, governments, and Native American tribes.
- The settlement aims to address claims that OxyContin fueled over 850,000 opioid deaths since 1999 and will distribute funds over years to support recovery and hold suppliers accountable.
115 Articles
115 Articles
The Independent
The Independent (US)Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement
Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.
South Carolina to receive nearly $73 million from national opioid settlement
South Carolina will receive $72.8 million as part of a $7.4 billion settlement with one of the nation's largest pharmaceutical providers. (File photo by Getty Images)South Carolina will receive $72.8 million to support drug addition treatment, prevention and recovery as part of a multi-state settlement with one of the nation’s largest pharmaceutical providers. Attorneys general, representing all 50 states, Washington D.C. and four U.S. territori…
10/11 News
ncdoj.gov55 Attorneys General Sign On to $7.4 Billion Purdue Settlement
Attorney General Hilgers announced on Monday that all 55 attorneys general, representing all eligible states and U.S. territories, agreed to sign on to a $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family.
Coverage Details
Bias Distribution
- 73% of the sources are Center
To view factuality data please Upgrade to Premium
